Baxter and Satellite Healthcare Partner to Bring Dialysis Care to More Patients

Baxter International Inc. a global force in renal care, and Satellite Healthcare, a national not-for-profit and the sixth largest provider of patient-centered dialysis and kidney disease services in the U.S.,¹ today announced an agreement to provide patients with the latest advancements in peritoneal dialysis, hemodialysis, and continuous renal replacement therapy.
 
Under the four-year agreement, Satellite Healthcare plans to offer AMIA Automated Peritoneal Dialysis (APD) system with SHARESOURCE to peritoneal dialysis (PD) patients, and integrate REVACLEAR into its high-flux hemodialysis therapy offering at its 80 Satellite Dialysis and Satellite WellBound home dialysis centers that serve more than 7,000 patients nationwide. Details of the agreement were not disclosed.
 
”Baxter and Satellite Healthcare share a common goal to provide patients with a better dialysis experience,” said Giuseppe Accogli, corporate vice president and president, Baxter Renal. ”We are pleased to continue our relationship with an organization that is clearly leading the way and revolutionizing how kidney disease patients are cared for in the U.S.”
 
Satellite Healthcare launched Re-Imagine Home, a long-term initiative to change the landscape of home dialysis with the design of an industry-leading home dialysis model. The aspirational goal through Re-Imagine Home is to double Satellite Healthcare’s home dialysis usage from 20% to 40% of its patient population and increase awareness of home dialysis.
 
”Our mission is to make life better for our kidney disease patients by offering a personalized care experience that is unlike any other,” said Satellite Healthcare CEO Rick Barnett. ”AMIA, Baxter’s new technology, is a foundational tool for Satellite Healthcare in reaching our Re-Imagine Home goal to make home dialysis an accessible and effective modality option for more dialysis patients.”
 
AMIA APD System with SHARESOURCE
Baxter’s AMIA APD system with SHARESOURCE, which was launched in late 2015, was designed to help more patients manage therapy at home. The system’s patient-centric features include voice guidance, a touchscreen control panel and SHARESOURCE, Baxter’s cloud-based telemedicine platform.
 
Clinicians can use SHARESOURCE to securely and remotely manage their home dialysis patients. SHARESOURCE provides clinicians with on-demand access to dialysis-related treatment data, which automatically collects after each PD session, and the ability to remotely adjust device programs.
 
REVACLEAR High-Flux Dialyzer
Dialyzers serve an important function during hemodialysis, as they act as a filter to remove toxins from the blood. REVACLEAR, a high-flux dialyzer, contains a three-layer polyarylethersulfone membrane, which has been designed to provide selective permeability and minimal resistance to diffusion.² REVACLEAR dialyzers are indicated for treatment of chronic and acute renal failure by hemodialysis.
 
References
¹Nephrology News & Issues 2016 10 Largest Dialysis Providers Report, Figure 1.http://www.nephrologynews.com/largest-dialysis-providers-2016-poised-change/. Accessed 8/18/16.
²Ronco C, et al. Nephrol Dial Transplant 2003; 18 (Suppl 7):vii10–vii20; Ward RA & Ouseph R. Abstract presented at the 40th ASN congress. San Francisco (USA). 2007. [abstract SA-PO510]; Bhimani JP, et al. Nephrol Dial Transplant 2010; 25:3990–3995; Data on file. May 2013. Nilsson LG, Beck W and Bosch J. REVACLEAR White Paper. (USMP/MG3/140052).